Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 09/19/2025 | CALL | $24.00 | 1,688 | +524 | +45.02% |
| 01/15/2027 | CALL | $15.00 | 643 | +298 | +86.38% |
| 01/16/2026 | CALL | $60.00 | 567 | +108 | +23.53% |
| 06/20/2025 | CALL | $45.00 | 1,672 | +100 | +6.36% |
| 09/19/2025 | CALL | $41.00 | 175 | +57 | +48.31% |
| 11/21/2025 | CALL | $60.00 | 167 | +40 | +31.50% |
| 01/15/2027 | CALL | $37.00 | 127 | -20 | -13.61% |
| 05/16/2025 | CALL | $21.00 | 2,821 | -22 | -0.77% |
| 05/23/2025 | CALL | $35.00 | 89 | -37 | -29.37% |
| 09/19/2025 | CALL | $18.00 | 5,315 | -68 | -1.26% |
| 05/16/2025 | CALL | $35.50 | 327 | -73 | -18.25% |
| 05/16/2025 | PUT | $40.00 | 579 | -96 | -14.22% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 4.30% | 6.43M | 163.69M |
| Vanguard Total Stock Market Index Fund | 2.65% | 3.97M | 100.95M |
| Vanguard Small-Cap Index Fund | 2.26% | 3.37M | 85.8M |
| Vanguard Specialized-Health Care Fund | 2.05% | 3.07M | 78.07M |
| iShares Russell 2000 ETF | 1.97% | 2.94M | 74.81M |
| Vanguard Small-Cap Growth Index Fund | 1.30% | 1.94M | 49.42M |
| Vanguard Extended Market Index Fund | 1.28% | 1.91M | 48.54M |
| Fidelity Select Portfolios - Biotechnology | 1.15% | 1.72M | 43.76M |
| ACAP Strategic Fund | 1.00% | 1.5M | 38.21M |
| Fidelity Growth Company Fund | 0.95% | 1.43M | 36.29M |
TG Therapeutics Reports First Quarter 2025 Financial Results and Raises BRIUMVI Full Year Revenue Guidance
05/05 07:00 am
GlobeNewswire Inc.
Read moreBilibili, MARA And ZEEKR Are Among Top 8 Mid-Cap Gainers Last Week (Mar 3-Mar 7): Are The Others In Your Portfolio?
03/09 01:19 pm
Benzinga
Read moreTG Therapeutics to Participate in the Evercore HealthCONx Conference
11/29 09:00 am
GlobeNewswire Inc.
Read moreTG Therapeutics Ranked Number One Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™
11/21 07:00 am
GlobeNewswire Inc.
Read more"Rule Breaker Investing" Market Cap Game Show: Bill Mann vs. Bill Barker
06/27 01:55 pm
The Motley Fool
Read moreTG Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
06/07 07:50 am
GlobeNewswire Inc.
Read moreTG Therapeutics to Participate in the Jefferies Global Healthcare Conference
06/03 07:30 am
GlobeNewswire Inc.
Read moreTG Therapeutics Announces Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024 Consortium of Multiple Sclerosis Centers Annual Meeting
05/31 07:30 am
GlobeNewswire Inc.
Read moreTG Therapeutics Announces Schedule of Upcoming Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024 Consortium of Multiple Sclerosis Centers Annual Meeting
05/28 07:30 am
GlobeNewswire Inc.
Read moreWall Street Breakfast: The Week Ahead
05/12 07:04 am
Seeking Alpha
Read moreWhy TG Therapeutics Stock Was Rocketing Higher This Week
05/03 05:56 am
The Motley Fool
Read moreTG Therapeutics (TGTX) Reports Q1 Loss, Tops Revenue Estimates
05/01 08:30 am
Zacks Investment Research
Read moreTG Therapeutics to Host Conference Call on First Quarter 2024 Financial Results and Business Update
04/30 04:55 pm
GlobeNewswire Inc.
Read moreAfter Plunging -9.82% in 4 Weeks, Here's Why the Trend Might Reverse for TG Therapeutics (TGTX)
04/30 09:35 am
Zacks Investment Research
Read moreTG Therapeutics Announces Additional Data Presentations for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting
04/18 07:30 am
GlobeNewswire Inc.
Read moreTG Therapeutics Awarded National Contract by the Department of Veterans Affairs for BRIUMVI as the Preferred Anti-CD20 for Relapsing Forms of Multiple Sclerosis
04/18 07:00 am
GlobeNewswire Inc.
Read moreTG Therapeutics Announces Presentation of Data for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting
04/15 07:30 am
GlobeNewswire Inc.
Read moreShould You Invest in the SPDR S&P Biotech ETF (XBI)?
03/25 06:20 am
Zacks Investment Research
Read moreTG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting
03/08 08:30 am
GlobeNewswire Inc.
Read moreRare Stock Picks In February 2024 - From 32 Discerning Analysts
03/05 11:00 am
Seeking Alpha
Read moreTG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum
03/01 08:30 am
GlobeNewswire Inc.
Read moreCompany News for Feb 29, 2024
02/29 10:39 am
Zacks Investment Research
Read moreAdvance Auto Parts Reports Q4 Results, Joins B&G Foods, Vipshop, ADT And Other Big Stocks Moving Higher On Wednesday
02/28 12:37 pm
Benzinga
Read moreTG Therapeutics (TGTX) Reports Q4 Loss, Tops Revenue Estimates
02/28 09:10 am
Zacks Investment Research
Read moreTG Therapeutics Provides Business Update and Reports Fourth Quarter and Year-End 2023 Financial Results
02/28 08:00 am
GlobeNewswire Inc.
Read moreTG Therapeutics Announces Issuance of Additional Patents for BRIUMVI® (ublituximab-xiiy)
02/27 08:30 am
GlobeNewswire Inc.
Read moreTG Therapeutics to Host Conference Call on Fourth Quarter and Year-End 2023 Financial Results and Business Update
02/23 08:30 am
GlobeNewswire Inc.
Read moreIs SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?
02/22 07:20 am
Zacks Investment Research
Read moreWill TG Therapeutics (TGTX) Report Negative Q4 Earnings? What You Should Know
02/20 11:00 am
Zacks Investment Research
Read moreBio-Rad Laboratories (BIO) Surpasses Q4 Earnings Estimates
02/15 06:30 pm
Zacks Investment Research
Read moreZimmer Biomet (ZBH) Q4 Earnings and Revenues Surpass Estimates
02/08 08:40 am
Zacks Investment Research
Read moreHC Wainwright & Co. Maintains Buy Rating for TG Therapeutics: Here's What You Need To Know
01/11 01:00 pm
Benzinga
Read moreVeradigm, Aehr Test Systems, Saratoga Investment And Other Big Stocks Moving Lower On Wednesday
01/10 11:27 am
Benzinga
Read morePriceSmart Posts Upbeat Earnings, Joins SMART Global, Intuitive Surgical And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session
01/10 06:18 am
Benzinga
Read moreRobinhood, Couchbase And 2 Other Stocks Insiders Are Selling
01/09 09:07 am
Benzinga
Read moreTG Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
01/05 08:30 am
GlobeNewswire Inc.
Read moreTHOR Industries Reports Upbeat Earnings, Joins Dave & Buster's Entertainment, Campbell Soup And Other Big Stocks Moving Higher On Wednesday
12/06 11:48 am
Benzinga
Read moreTG Therapeutics to Participate in the 6th Annual Evercore ISI HealthCONx Conference
11/27 08:30 am
GlobeNewswire Inc.
Read moreDoes TG Therapeutics (TGTX) Have the Potential to Rally 127.76% as Wall Street Analysts Expect?
11/06 10:55 am
Zacks Investment Research
Read moreTG Therapeutics to Participate in the 5th Annual Guggenheim Inflammation, Neurology & Immunology (INI) Conference
11/03 07:30 am
GlobeNewswire Inc.
Read moreDow Gains Over 100 Points; Fed Leaves Interest Rates Unchanged
11/01 02:33 pm
Benzinga
Read moreWhy TG Therapeutics Stock Is Crushing It Today
11/01 12:18 pm
The Motley Fool
Read moreGarmin, Apollo Global Management, Trane Technologies, Scotts Miracle-Gro And Other Big Stocks Moving Higher On Wednesday
11/01 11:09 am
Benzinga
Read moreTG Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial Results
11/01 07:30 am
GlobeNewswire Inc.
Read more